Wed. 3 Apr 2024, 8:33am ET
Benzinga
Earnings, News
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 30.43 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $3.23 million which beat the analyst consensus estimate of $3.14 million by 2.83 percent. This is a 4.67 percent increase over sales of $3.08 million the same period last year.